Trials / Conditions / Malignant Pleural Mesothelioma (MPM)
Malignant Pleural Mesothelioma (MPM)
6 registered clinical trials studyying Malignant Pleural Mesothelioma (MPM) — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | Oral TEAD Inhibitor Targeting the Hippo Pathway in Subjects with Advanced Solid Tumors NCT05228015 | Ikena Oncology | Phase 1 |
| Recruiting | A Study of NX-1607 in Adults With Advanced Malignancies NCT05107674 | Nurix Therapeutics, Inc. | Phase 1 |
| Active Not Recruiting | Mesothelin-targeted CAR T-cell Therapy in Patients With Mesothelioma NCT04577326 | Memorial Sloan Kettering Cancer Center | Phase 1 |
| Withdrawn | A Phase Ib Trial of a Maintenance Multipeptide Vaccine (S-588210) in Patients With Unresectable Malignant Pleu NCT02661659 | University of Chicago | Phase 1 |
| Completed | Metronomic Chemotherapy Based on Adaptative Bio-mathematical Model of Oral Vinorelbine in Patients With NSCLC NCT02555007 | Assistance Publique Hopitaux De Marseille | Phase 1 |
| Completed | Clinical and Histopathologic Characteristics of BAP1 Mutations NCT01773655 | Memorial Sloan Kettering Cancer Center | — |